Benitec Biopharma Limited announced that Cliff Holloway has resigned from his position as Chief Business and Operations Officer, effective early January 2018, in order to pursue other interests overseas. Cliff will work with the rest of the executive leadership team to ensure a seamless transition. In the event of any transition period, Greg West, the company's Chief Executive Officer, will manage the function.